Targeting Interleukin-15 in Patients With Rheumatoid Arthritis: A Proof-of-Concept Study
For weight management, NICE recommends semaglutide 2.4mg (Wegovy) for adults with a BMI 35 kg/m (or 30 kg/m with weight-related comorbidities) within specialist weight management services alongside lifestyle interventions (TA875)
It develops when the immune system overreacts, attacking intestinal tissue and triggering ulcers, pain, and bleeding
- Flow Wellness, accessed April 22, 2025, 8 Zepbound Side Effects: Common and Severe and How to Manage Them - NP2GO, accessed April 22, 2025, GLP-1 physiology informs the pharmacotherapy of obesity - PubMed, accessed April 22, 2025, Creating a GLP-1 Meal Plan | Visit MRC Auburn - Metabolic Research Center, accessed April 22, 2025, Food Noise and Semaglutide: Can GLP-1 Medications Quiet the Chatter
In contrast to the potential dangerous effects in the acceleration of atherosclerosis, mixed results have been reported with L-carnitine supplementation in the immediate setting following an acute myocardial infarction (AMI)